share_log

Replimune Group Inc. Expects Enrollment Of First Patients In Phase 3 Confirmatory Trial Of RP1 In Advanced Melanoma In 2H 2024

Benzinga ·  May 16 20:11
Replimune Group Inc. Expects Enrollment Of First Patients In Phase 3 Confirmatory Trial Of RP1 In Advanced Melanoma In 2H 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment